Trends in pregnancy labeling and data quality for US-approved pharmaceuticals
- 1 December 2014
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 211 (6) , 690.e1-690.e11
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Management of Hypertension in PregnancyAdvances in Chronic Kidney Disease, 2013
- A review of pharmaceutical labeling for overdose treatment and toxicity dataPharmacoepidemiology and Drug Safety, 2013
- Evolving knowledge of the teratogenicity of medications in human pregnancyAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008American Journal of Obstetrics and Gynecology, 2011
- Isotretinoin, pregnancies, abortions and birth defects: a population‐based perspectiveBritish Journal of Clinical Pharmacology, 2007
- A survey of pregnant women using isotretinoinBirth Defects Research Part A: Clinical and Molecular Teratology, 2005
- Communicating risks during pregnancy: A workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugsBirth Defects Research Part A: Clinical and Molecular Teratology, 2004
- Medication during pregnancy: an intercontinental cooperative studyInternational Journal of Gynecology & Obstetrics, 1992
- Blood Volume Changes in Normal PregnancyClinics in Haematology, 1985